Solid biosciences reports 1.5-year data from patients in the ongoing ignite dmd phase i/ii clinical trial of sgt-001

- data support continued functional benefit 1.5 years post treatment compared with natural history data; assessed by north star ambulatory assessment (nsaa), 6-minute walk test (6mwt) and forced vital capacity (fvc) -

SLDB Ratings Summary

SLDB Quant Ranking